McVeigh Associates Ltd

Frank McVeigh, President and CEO
McVeigh Associates Ltd

Testimonials (pdf)

Contact McVeigh Associates Ltd.

Amityville, N.Y.
(631) 789-8833


LEADERSHIP: Frank McVeigh, President and CEO; Robert G. LeValley, Executive Vice President & Managing Partner; Ellen Montuori Graziano, Executive Vice President & Managing Partner

AT A GLANCE: In addition to remaining an industry leader in meeting, association & incentive management, McVeigh Associates has had a very productive year focusing on expanding their business and increasing their core service offerings for the meeting management industry. McVeigh Associates continues to partner with existing and new clients to provide a wide array of consultative services.

Some of the services include; partnering with Fortune 500 corporations to set up or further develop their SMMP initiatives, integrating new technologies with corporate protocols, consultative services for air and hotel procurement / spend management, expanding international hotel sourcing services and setting up systems /standards within the Pharmaceutical arena to capture per person spend for Federal reporting requirements .

McVeigh Associates continues to focus on technology to remain on the forefront of innovation and works diligently analyzing trends and efficiencies to ensure global strategic enterprise-wide alignment and positioning for all their clients with a focus on cost savings / cost avoidance.

They are proud to announce that Global Meetings, Ltd., a fully owned subsidiary of McVeigh Associates, is celebrating its 12th Anniversary this year. Global Meetings specializes in exhibit housing management and securing room blocks for international congresses.

  • Corporate meetings in 2010: 792
  • Incentive travel programs in 2010: 18
  • Meeting and incentive travel programs held outside the U.S.: 38%
  • Room nights booked for meetings and incentives: 120,156
  • % of revenue from planning and executing meetings and incentives: 91%
  • Full-time employees: 76
  • Top customer markets: pharmaceutical, healthcare/medical